Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Column

Pharma Insights
Value Transformation: Observations on the Second Annual Evaluation Report of the Oncology Care Model
03/13/2019
Maureen Hennessey, PhD, CPCC, CPHQ
Linda Bolland, PharmD, MBA
Larry Blandford, PharmD—Column Editor
The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...
The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...
The...
03/13/2019
Journal of Clinical Pathways
Clinical Pathways GPS
Pathways for Paying for Rare Disease Treatments
02/22/2019
Matthew Pakizegee, PharmD, MS
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Determining how to pay for the treatment of uncommon yet serious diseases is an important consideration in terms of sustainability and patient access. Novel and expensive therapies will create financial pressure for...
Determining how to pay for the treatment of uncommon yet serious diseases is an important consideration in terms of sustainability and patient access. Novel and expensive therapies will create financial pressure for...
...
02/22/2019
Journal of Clinical Pathways
Editor's Page
Quantifying Resource Use and the Role of Pathways in Reimbursement
02/19/2019
Winston Wong, PharmD, Editor-in-Chief
The delivery of cancer care is inevitably influenced by payment forces. In the ongoing transition from volume- to value-based payment, clinical pathways can serve as an integral tool for successful and streamlined...
The delivery of cancer care is inevitably influenced by payment forces. In the ongoing transition from volume- to value-based payment, clinical pathways can serve as an integral tool for successful and streamlined...
The...
02/19/2019
Journal of Clinical Pathways

Advertisement

Editorial
#COA2019: The Most Comprehensive Meeting for Community Oncology
02/19/2019
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...
The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...
The...
02/19/2019
Journal of Clinical Pathways
PATIENT PERSPECTIVE
Talking With Patients About Clinical Trials
02/19/2019
Alan Balch, PhD—Column Editor
Communicating with patients about clinical trials can be a daunting task, especially when many individuals have misconceptions about the nature of clinical trials, confusion about what tasks are involved in...
Communicating with patients about clinical trials can be a daunting task, especially when many individuals have misconceptions about the nature of clinical trials, confusion about what tasks are involved in...
...
02/19/2019
Journal of Clinical Pathways
Editor's Page
Where We Are With Value Assessment & Innovative Care and Reimbursement Models
12/13/2018
Winston Wong, PharmD, Editor-in-Chief
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...
As the...
12/13/2018
Journal of Clinical Pathways

Advertisement

Counterpoint
Quality Measurement as a Tool for a Patient-Centered Approach to Assessing Value
12/13/2018
Tom Valuck, MD, JD
Russ Montgomery, PhD, MHS
Current quality measures usually assess performance against a standard of care for a typical patient rather than the specific patient receiving care, much like value frameworks assess value for a typical patient....
Current quality measures usually assess performance against a standard of care for a typical patient rather than the specific patient receiving care, much like value frameworks assess value for a typical patient....
...
12/13/2018
Journal of Clinical Pathways
Viewpoint
Personalized Medicine in a World of Value Frameworks
12/13/2018
Robert W Dubois, MD, PhD
Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag....
Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag....
Health...
12/13/2018
Journal of Clinical Pathways
Pharma Insights
ACOs: Changing Health Care Cost and Quality to Be Accountable
12/13/2018
Marylou Buyse, MD, MS
Maureen Hennessey, PhD, CPCC, CPHQ
Larry Blandford, PharmD—Column Editor
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
...
12/13/2018
Journal of Clinical Pathways

Advertisement

Clinical Pathways GPS
Value-Based Clinical Pathways in the World of Reference-Priced Medicare Part B Drugs
12/13/2018
Matthew Pakizegee, PharmD, MS
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test  whether using a combination of 3 approaches—an international drug...
The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test  whether using a combination of 3 approaches—an international drug...
The...
12/13/2018
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use